Compare FBIN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBIN | PCVX |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.0B |
| IPO Year | N/A | 2020 |
| Metric | FBIN | PCVX |
|---|---|---|
| Price | $51.18 | $47.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $65.56 | ★ $101.67 |
| AVG Volume (30 Days) | ★ 1.5M | 1.5M |
| Earning Date | 02-05-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.67 | N/A |
| Revenue | ★ $4,489,900,000.00 | N/A |
| Revenue This Year | $0.09 | N/A |
| Revenue Next Year | $2.30 | N/A |
| P/E Ratio | $19.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $44.04 | $27.66 |
| 52 Week High | $75.82 | $93.77 |
| Indicator | FBIN | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 53.31 | 55.66 |
| Support Level | $49.58 | $42.40 |
| Resistance Level | $51.49 | $48.65 |
| Average True Range (ATR) | 1.34 | 1.61 |
| MACD | -0.03 | 0.22 |
| Stochastic Oscillator | 54.19 | 77.06 |
Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.